文献速递免疫规划

婴儿期接种乙型肝炎疫苗后的长期免疫力:真实世界数据分析

Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
PubMed 文献 · Vaccine · 2018-03-21

显示抗体水平随时间下降,15年后仅约三分之一人群保持保护水平,但再接种后93.8%的血清阴性者出现回忆应答,乙型肝炎表面抗原阳性率较低。

要点

  • 接种后抗-HBs抗体水平随时间下降,15-20年组平均为16.39 mIU/ml(P < 0.001)。
  • 15年后阴性结果比例逐渐增至66.7%(P < 0.001)。
  • 644名血清阴性者中604人(93.8%,95%CI:91.6-95.5%)在加强接种后转为血清阳性。

核心结论

  • 接种后抗-HBs抗体逐渐下降,15年后仅约三分之一人群保持保护水平。
  • 青少年期回忆应答显示几乎所有再接种青少年均表现出免疫。
  • 尽管几乎所有新生儿均接种疫苗,仍观察到较低的乙型肝炎感染率。

研究设计与样本

  • 纳入1992年1月至2014年12月出生并检测乙型肝炎表面抗体的所有研究对象,共20634名受试者。
  • 接种后年数按5年分组,计算HBV免疫血清阳性率的线性趋势,并评估回忆应答和乙型肝炎表面抗原存在情况。

主要发现

  • 检测时平均(±SD)年龄为14.8(±5.4)岁。
  • 平均抗-HBs抗体水平随时间下降至15-20年组的16.39 mIU/ml(P < 0.001)。
  • 阴性结果比例逐渐增至15年后的66.7%(P < 0.001)。
  • 644名血清阴性受试者中604名(93.8%,95%CI:91.6-95.5%)在加强剂量后转为血清阳性。
  • 20634名参与者中检出乙型肝炎表面抗原91例(每1000名研究参与者4.4例)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis B virus (HBV) vaccination has decreased the prevalence of chronic HBV infections and their sequelae. However, whether vaccination at birth provides lifelong protection is unclear. OBJECTIVE: To assess long-term immunity following neonatal HBV immunization in a large population-based cohort. METHODS: Using the database of a 2 million member sick fund in Israel, we identified all subjects born after introduction of universal HBV vaccination in Israel (January 1992 through December 2014), that were tested for hepatitis B surface antibody (anti-HBs Ab's). Years since vaccination were categorized into 5-year groups and linear trends in the seroprevalence of HBV immunity were calculated. Anamnestic response and presence of Hepatitis B surface antigen (HBs Ag) were assessed. RESULTS: Included were 20,634 tested individuals. Mean (±SD) age at testing was 14.8 (±5.4) years. Mean anti-HBs Ab levels declined with time to 16.39 mIU/ml in the 15-20 year group (P < 0.001). The proportion of negative results increased gradually (P < 0.001) to 66.7% after 15 years. Anamnestic response assessment showed that 604 of 644 seronegative subjects (93.8%, 95% CI: 91.6-95.5%) became seropositive after a booster dose. HBs Ag was identified in 91 of the 20,634 (4.4 per 1000 study participants). CONCLUSIONS: Following vaccination, anti-HB's Ab's progressively decline, with only a third of the population retaining protective levels after 15 years. In adolescence, anamnestic response shows that nearly all revaccinated adolescents exhibit immunity. A low rate of Hepatitis B infection was demonstrated despite vaccination of nearly all newborns.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Klinger G, Chodick G, Levy I, et al. Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis. Vaccine. 2018. PMID: 29573878. doi:10.1016/j.vaccine.2018.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。